How Improved Health and Longer Lives Drive Global Prosperity (updated)

Panel Composition and Context

• The session, part of "Milk and Palooza," features a panel of six experts: Cece Connolly (PwC Health Research Institute), Dr. Thomas Frieden (CDC), Jonathan Gluck (Heritage Provider Network), Carol Roane (Georgetown/RAND), Mike Harsh (GE Health Care), and Dr. Peter Margolis (University of Cincinnati).
• The core objective is to examine the causal links between healthcare innovation, economic growth, and productivity, while debunking myths regarding cost containment.

Economic Impact of Specific Innovations

• Immunizations generate a 10-to-1 return on investment (ROI) for societal costs and a 3-to-1 ROI for direct medical costs, saving $10 billion in the economy and $3 billion in healthcare per $1 invested.
• Annual immunization efforts prevent approximately 20 million disease cases and save 42,000 lives while injecting $70 billion into the general economy.
• Advanced medical imaging (CT, MRI, PET) has reduced exploratory surgeries by nearly 60% since the late 1970s, generating approximately $14 billion in net healthcare savings.
• Telehealth interventions for low-income diabetics in Hawaii utilize remote foot imaging to prevent neuropathy-related amputations, piloted through the Center for Medicare and Medicaid Innovation (CMMI).
• Collaborative care networks (e.g., Improved Care Now) have increased remission rates for pediatric Crohn's disease from 60% to 77% without new medications by standardizing care protocols.

Systemic Challenges and Cost Drivers

• The U.S. healthcare system currently operates at a $2.8 trillion annual spend, with the majority driven by fee-for-service models that pay for volume rather than health outcomes.
• Empirical research indicates that rising healthcare costs negatively impact U.S. firm competitiveness and job creation in industries with high employer-sponsored insurance, despite economic theory suggesting wages could adjust downward.
• Only 25% of patients currently receive the correct care at the correct time due to systemic failures in care delivery and patient adherence.
• The U.S. controls high blood pressure in only 47% of affected Americans, compared to 75-85% in high-performing systems, despite simple feedback loops being proven effective.

Incentive Structures and Data Utilization

• Heritage Provider Network utilizes "prize challenges" to crowdsource solutions, leveraging the principle that for well-formulated prizes, the effort invested by solvers is 10-20 times the prize value.
• The Heritage Health Prize attracted 39,000 entries from non-healthcare data scientists (e.g., hedge funds) to predict hospital admissions, aiming to eliminate the $40 billion spent on unnecessary hospital care.
• Big data application in pediatrics allows for "simulated trials" comparing expensive biologic drugs (e.g., Remicade, $50,000/year) against routine care in months rather than years, at a fraction of the cost.
• Healthcare data volume is described as sufficient to fill 500,000 new libraries of Congress, yet remains underutilized compared to industries like credit card services.
• Dr. Harsh asserts that eliminating 1% of clinical and diagnostic variation in care could yield $60-$63 billion in annual savings, necessitating the "industrialization" of healthcare.

Forward-Looking Statements and Debunked Myths

• Myth: Innovation must always be high-tech.
  • Reality: The most effective innovations are often low-tech (e.g., checklists, community health workers) or involve shifting roles from doctors to broader care teams.
• Myth: Healthcare reform is purely an intellectual challenge.
  • Reality: The primary barriers are political, specifically regarding end-of-life discussions and shifting payment models from volume to value.
• Myth: Universal insurance stifles economic growth.
  • Reality: Removing employer-tethered insurance (via ACA exchanges) fosters entrepreneurship, as individuals are less locked into jobs for coverage.
• Future Vision: Dr. Frieden advocates for establishing "healthy defaults" (analogous to fluoridated water or smoke-free laws) to prevent illness rather than treating it, requiring political leadership and community advocacy.
• Technology Evolution: GE Health Care is developing palm-sized, point-of-care ultrasound devices that function as "21st-century stethoscopes," enabling global access to cardiac diagnostics via reverse innovation.
• Patient Engagement: Collaborative networks are increasingly integrating patients into governance and design, shifting decision-making from physician-centric to shared ownership.